Cardiac malonyl CoA levels are decreased in diabetes as a result of a decrease in its synthesis by acetyl-CoA carboxylase (ACC) [86] and/or an increased degradation by malonyl CoA decarboxylase (MCD) [87]. This evidence concerns the gene MLYCD and diabetes mellitus.